ZimVie Makes Needed Cuts in First Quarter of 2022

ZimVie reported 1Q22 orthopedic sales of $114.1 million, -13.9% compared to 1Q21.

In the short term, the company is focused on stability in the wake of its separation from Zimmer Biomet. Work remains to be done in setting up regional infrastructure for international spine sales.

ZimVie exited some unprofitable geographies in the first...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us